Artrya is an applied artificial intelligence healthcare company that is working to improve the diagnosis of heart disease.
It develops artificial intelligence tools for clinicians to improve the diagnosis of coronary heart disease, and to predict and prevent acute coronary events.
Artrya listed on the ASX on 26 November 2021.